RxDoctor Payments Data

Arshneel Kochar, MD

Clinical Cardiac Electrophysiology · Cleveland, OHNPI 1679968085

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.8%), grants and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Abbott at 43.4% of the total. Reporting peaked in 2022 at $26,582 and has fallen 86.8% since, to $3,511 in 2025.

$48,908in general payments, 2019–2025

Across 245 payments — averaging $199.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$21K
  • Boston Scientific$12K
  • Medtronic$11K
  • Biotronik Inc.$4K
  • Philips North America LLC$322
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$87
  • plus $55 from 2 others

What the payments were for

  • Grants$15,00031%
  • Travel & lodging$22,40146%
  • Food & beverage$10,67622%
  • Education$8312%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,908 in reported general payments places this provider in the 80th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio

Medicare billing

Part B allowed, 2024
$117,502
Medicare patients
597
Services billed
1,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban134$122,707
XareltoRivaroxaban19$11,568
Flecainide Acetate33$3,348
Metoprolol Succinate114$1,500
Amiodarone Hcl37$449
Carvedilol17$187

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →